Latest filing published 07 Apr 2022 for Everest Medicines Ltd..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jiang Shidong: trading record in brief
Jiang Shidong discloses dealings in Everest Medicines Ltd. to HKEX. Between 14 July 2021 and 1 April 2022, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases and not one sale. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2022 alone, the filings show 2 purchases and no sales.
Most recently, on 7 April 2022, the filings show an open-market purchase in Everest Medicines Ltd. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jiang Shidong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 sharesShareXHKGHKEX:DA20220407E00523Canonical exit: 30 Jun 2022 (T+90)
- 20,000 sharesShareXHKGHKEX:DA20220309E00276Canonical exit: 12 Oct 2021 (T+90)
2 of 2 declarations